Name
Osaühing FibroTx
Registry code
11183541
VAT number
EE101015402
Type
OÜ - Limited Liability Company
Status
In liquidation
Foundation date
07.11.2005 (20)
Financial year
01.01-31.12
Capital
80 000.00 €
Activity
72111 - Research and experimental development on biotechnology
-
-232 565 €
-
-
-11 345 162 €
-
Submitted
No tax arrears
2%
-11628250%
| Owner | Representative | Beneficial owner | |
|---|---|---|---|
| Omanikukonto: AIVAR LINNAMÄE
| - | Liquidator | Indirect ownership |
| OÜ Lost Gorillas 16211897 | 3% - 2 400.00 EUR | - | - |
| AKH Investeeringud OÜ 11934160 | 24% - 19 200.00 EUR | - | - |
| Osaühing ProtoBioS 10981915 | 18% - 14 400.00 EUR | - | - |
| Aifal OÜ 12411530 | 17% - 13 991.00 EUR | - | - |
| OÜ Kähri & Kaarin 11208488 | 13% - 10 209.00 EUR | - | - |
| 2019 14.09.2020 | 2020 30.06.2021 | 2021 07.07.2022 | 2022 27.06.2023 | 2023 13.08.2024 | 2024 15.10.2025 | |
|---|---|---|---|---|---|---|
| Total Revenue | 237 871 € | 164 291 € | 221 916 € | 52 978 € | - | - |
| Net profit (loss) for the period | -1 419 011 € | -1 131 487 € | -1 573 505 € | -5 006 232 € | -798 854 € | -232 565 € |
| Profit Margin | -597% | -689% | -709% | -9450% | - | - |
| Current Assets | 202 438 € | 47 010 € | 166 092 € | 607 € | 7 € | 2 € |
| Fixed Assets | 1 271 862 € | 1 515 584 € | 2 067 567 € | 0 € | - | - |
| Total Assets | 1 474 300 € | 1 562 594 € | 2 233 659 € | 607 € | 7 € | 2 € |
| Current Liabilities | 421 123 € | 691 274 € | 1 160 844 € | 10 314 350 € | 11 112 604 € | 11 345 164 € |
| Non Current Liabilities | 3 655 696 € | 4 605 326 € | 6 380 326 € | 0 € | - | - |
| Total Liabilities | 4 076 819 € | 5 296 600 € | 7 541 170 € | - | - | - |
| Share Capital | - | - | - | - | - | - |
| Equity | -2 602 519 € | -3 734 006 € | -5 307 511 € | -10 313 743 € | -11 112 597 € | -11 345 162 € |
| Employees | 14 | 9 | 9 | 7 | - | - |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2025 Q4 | 0 € | - | - | - |
| 2025 Q3 | 0 € | - | - | - |
| 2025 Q2 | 0 € | - | - | - |
| 2025 Q1 | 0 € | - | - | - |
| 2024 Q4 | 0 € | - | - | - |
| 2024 Q3 | 0 € | - | - | - |
| 2024 Q2 | 0 € | - | - | - |
| 2024 Q1 | 0 € | - | - | - |
| 2023 Q4 | 0 € | 0 € | 32 € | - |
| 2023 Q3 | 0 € | 0 € | 0 € | - |
| 2023 Q2 | 0 € | 0 € | 0 € | - |
| 2023 Q1 | 2 760 € | 17 627 € | 31 723 € | - |
| 2022 Q4 | 27 718 € | 0 € | 51 619 € | 9 |
| 2022 Q3 | 57 273 € | 0 € | 28 279 € | 9 |
| 2022 Q2 | 26 752 € | 0 € | 35 851 € | 17 |
| 2022 Q1 | 118 364 € | 12 549 € | 34 129 € | 20 |
